Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 10, 2026
KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: January 12, 2026
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy.
Journal: Annals of surgery
Published: October 29, 2024
Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
Journal: Annals of surgery
Published: January 23, 2024
Showing 1-4 of 4
Last Updated: 09/26/2026